Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Chronobiology International|September 3, 2020
Ambulatory blood pressure-based inclusion criteria in the Hygia Chronotherapy Trial. Rebuttal to Lemmer and MiddekeRamón C Hermida, Artemio Mojón, José R FernándezChronobiology International|August 31, 2004
Comparison of parameters from rhythmometric models with multiple components on hybrid dataJosé R Fernández, Artemio Mojón, Ramón C HermidaChronobiology International|July 21, 2020
Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy TrialRamón C Hermida, José R Fernández, Artemio MojónChronobiology International|July 21, 2020
Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as documented by MAPEC and Hygia Chronotherapy outcomes trialsRamón C Hermida, Artemio Mojón, José R FernándezChronobiology International|July 21, 2020
Chronotherapy of hypertension: advantages of 48-h ambulatory blood pressure monitoring assessments in MAPEC and Hygia Chronotherapy TrialJosé R Fernández, Artemio Mojón, Ramón C HermidaChronobiology International|November 8, 2012
Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular riskCristina Crespo, José R Fernández, Mateo Aboy, et al.Medical & Biological Engineering & Computing|March 3, 2012
Automatic identification of activity-rest periods based on actigraphyCristina Crespo, Mateo Aboy, José Ramón Fernández, et al.Chronobiology International|July 19, 2003
Methods for comparison of parameters from longitudinal rhythmometric models with multiple componentsJosé R Fernandez, Artemio Mojón, Ramón C Hermida, et al.Diabetologia|September 25, 2015
Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for preventionRamón C Hermida, Diana E Ayala, Artemio Mojón, et al.Diabetologia|September 25, 2015
Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trialRamón C Hermida, Diana E Ayala, Artemio Mojón, et al.Pageof 10